Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China
· Delayed Price · Currency is CNY 14.15
+0.12 (0.86%)
Mar 9, 2026, 3:04 PM CST
SHE:000403 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2020 - 2016 |
| Market Capitalization | 13,448 | 15,448 | 19,957 | 16,669 | 20,540 | 18,713 | Upgrade
|
| Market Cap Growth | -15.43% | -22.60% | 19.73% | -18.85% | 9.77% | 112.54% | Upgrade
|
| Enterprise Value | 13,239 | 14,283 | 18,990 | 15,725 | 19,928 | 18,927 | Upgrade
|
| Last Close Price | 14.15 | 16.00 | 20.33 | 16.91 | 20.78 | 28.17 | Upgrade
|
| PE Ratio | 23.78 | 20.73 | 32.60 | 28.39 | 52.52 | 100.62 | Upgrade
|
| Forward PE | 13.52 | 20.90 | 20.90 | 20.90 | 36.40 | 65.38 | Upgrade
|
| PS Ratio | 5.64 | 5.82 | 8.57 | 6.93 | 10.42 | 17.82 | Upgrade
|
| PB Ratio | 1.68 | 1.95 | 2.69 | 2.43 | 3.25 | 19.35 | Upgrade
|
| P/TBV Ratio | 2.58 | 3.02 | 4.34 | 4.11 | 5.85 | 20.80 | Upgrade
|
| P/FCF Ratio | - | - | 66.14 | 114.50 | 250.30 | 120.99 | Upgrade
|
| P/OCF Ratio | - | 48.01 | 29.39 | 31.80 | 50.32 | 96.04 | Upgrade
|
| EV/Sales Ratio | 5.56 | 5.38 | 8.15 | 6.54 | 10.11 | 18.03 | Upgrade
|
| EV/EBITDA Ratio | 18.60 | 15.63 | 24.64 | 22.32 | 37.04 | 69.09 | Upgrade
|
| EV/EBIT Ratio | 22.18 | 18.01 | 29.97 | 26.79 | 46.32 | 83.53 | Upgrade
|
| EV/FCF Ratio | -27.74 | - | 62.94 | 108.02 | 242.85 | 122.38 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.08 | 0.07 | 0.05 | 0.02 | 0.39 | Upgrade
|
| Debt / EBITDA Ratio | 1.45 | 0.71 | 0.64 | 0.52 | 0.26 | 1.39 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.64 | 2.57 | 1.72 | 2.46 | Upgrade
|
| Net Debt / Equity Ratio | -0.02 | -0.12 | -0.18 | -0.15 | -0.15 | 0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.29 | -1.04 | -1.76 | -1.49 | -1.82 | 1.01 | Upgrade
|
| Net Debt / FCF Ratio | 0.43 | 4.77 | -4.50 | -7.21 | -11.92 | 1.79 | Upgrade
|
| Asset Turnover | 0.26 | 0.30 | 0.28 | 0.32 | 0.45 | 0.71 | Upgrade
|
| Inventory Turnover | 0.90 | 1.26 | 1.47 | 1.69 | 1.80 | 1.27 | Upgrade
|
| Quick Ratio | 1.56 | 2.42 | 2.70 | 2.46 | 2.67 | 0.66 | Upgrade
|
| Current Ratio | 2.93 | 3.74 | 3.72 | 3.18 | 3.85 | 1.35 | Upgrade
|
| Return on Equity (ROE) | 7.07% | 9.71% | 8.56% | 8.91% | 10.73% | 20.66% | Upgrade
|
| Return on Assets (ROA) | 4.00% | 5.55% | 4.77% | 4.87% | 6.13% | 9.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.80% | 10.63% | 9.48% | 9.36% | 11.15% | 18.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 9.60% | 8.20% | 8.40% | 6.70% | 21.90% | Upgrade
|
| Earnings Yield | 4.16% | 4.83% | 3.07% | 3.52% | 1.90% | 0.99% | Upgrade
|
| FCF Yield | -3.55% | -1.29% | 1.51% | 0.87% | 0.40% | 0.83% | Upgrade
|
| Dividend Yield | 2.74% | 2.40% | 0.76% | 0.36% | 0.21% | - | Upgrade
|
| Payout Ratio | 67.40% | 35.50% | 10.91% | 8.46% | 3.08% | 96.17% | Upgrade
|
| Buyback Yield / Dilution | 0.80% | -0.28% | 0.33% | -3.38% | -44.25% | -0.21% | Upgrade
|
| Total Shareholder Return | 3.54% | 2.12% | 1.08% | -3.02% | -44.04% | -0.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.